| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003001909A2 A process for storing enriched nematodes |
| 01/09/2003 | WO2003001908A1 Hspc150-like gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003001906A1 Method of constructing joint disease model animal |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002024726A3 Olfactory and pheromones g-protein coupled receptors |
| 01/09/2003 | WO2002008407A3 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | US20030009777 Using galanin agonist in the generation of medicament for the treatment of nerve damage |
| 01/09/2003 | US20030009775 Mouse model for hepatitis C |
| 01/09/2003 | US20030009774 Trangenic rodent for use as model in evaluation of xenobiotics |
| 01/09/2003 | US20030009370 Method and apparatus for customizing a multiple component pet food |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030007963 Treatment of pompe's disease |
| 01/09/2003 | US20030005623 Crop weighing |
| 01/09/2003 | CA2452196A1 T cell regulatory genes and methods of use thereof |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1272853A2 Methods for identifying and using amyloid-inhibitory compounds |
| 01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 01/08/2003 | EP1272656A1 Human serine racemase |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272629A1 Genetic silencing |
| 01/08/2003 | EP1272208A2 Use of vegf and homologues to treat neuron disorders |
| 01/08/2003 | EP1272030A1 Methods for sexing non-human mammals |
| 01/08/2003 | EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 01/08/2003 | EP1001677A4 A novel method for treating epidermal or dermal conditions |
| 01/08/2003 | EP0996727B1 Gene conferring obese phenotype |
| 01/08/2003 | CN2529511Y High pureness scorpian venom extracting equipment |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1389105A Planar cocoon and its production process and planar notched plate special for producing planar cocoon |
| 01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
| 01/07/2003 | US6504081 Methods and uses for transposon-based gene targeting |
| 01/07/2003 | US6504080 Transgenic animal model for neurodegenerative disorders |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/04/2003 | CA2351156A1 A bioprocess for the generation of pluripotent cell derived cells and tissues |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003001198A1 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 01/03/2003 | WO2003001197A1 Assay for toxin induced neuronal degeneration and viability in c. elegans |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000885A1 Process for constructing mutant |
| 01/03/2003 | WO2003000882A2 Transgenic models for glucose homeostasis comrpising human gsk-3 |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000861A2 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000047A2 Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids |
| 01/03/2003 | WO2002079418A9 Gene regulation ii |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002012500A3 Anti-il-12 antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2451637A1 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451247A1 Eukaryotic genes involved in adult lifespan regulation |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2449613A1 Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids |
| 01/02/2003 | US20030005472 Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression |
| 01/02/2003 | US20030005470 Animal model for use in the diagnosis and treatment of tumors and bone matastasis |
| 01/02/2003 | US20030005469 Rodent animal model for use in the diagnosis, prevention and treatment of arthritic diseases |
| 01/02/2003 | US20030005468 Methods and vectors for improving nucleic acid expression |
| 01/02/2003 | US20030004733 Pet food kiosk |
| 01/02/2003 | US20030004655 Methods and apparatus for customizing pet food |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030003581 Method for targeting transcriptionally active loci |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003478 Identifying and characterizing genes |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | EP1269837A2 Allergen-containing milk for allergy treatment |
| 01/02/2003 | EP1269836A1 Animals with high histamine productivity |
| 01/02/2003 | EP1269180A1 Methods for screening and identifying pathogen virulence factors |
| 01/02/2003 | EP1268837A1 Method of generating transgenic organisms using transposons |
| 01/02/2003 | EP1268836A2 Novel sperm-dna complexes for genetically modifying non-human animals |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 01/02/2003 | EP1268535A2 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene. |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267627A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof |
| 01/02/2003 | EP0662138B1 Long wap promoter for mammary expression of human protein c |
| 01/01/2003 | CN2528221Y 蚯蚓生物反应器 Earthworms bioreactor |
| 01/01/2003 | CN2528220Y Bag for gathering of newly hatched silkworms |
| 01/01/2003 | CN1387756A Automatic liquid-dropping mechanism for artificial insect egg culture |
| 12/31/2002 | US6501003 Mouse transformed with a humanized mutant of green fluorescent protein operably linked to the glial fibrillary acidic protein promoter; use determining the neurotoxicity of a substance |
| 12/31/2002 | US6500929 Protein containing a functional domain of a water-soluble c1 inhibitor and an anchor molecule; suppressing complement activity; membrane bound complement regulatory proteins; transplantation |